{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:02:23Z","timestamp":1790816543998,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NV 19-09-00125"],"award-info":[{"award-number":["NV 19-09-00125"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00392-022-02008-z","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T17:02:43Z","timestamp":1647622963000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Heart failure-related quality-of-life impairment after myocardial infarction"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-526X","authenticated-orcid":false,"given":"Peter","family":"Wohlfahrt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Jen\u010da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Stehlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojt\u011bch","family":"Melenovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolana","family":"Mr\u00e1zkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Stan\u011bk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Kettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"\u0160ramko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"\u017del\u00edzko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u011bra","family":"Ad\u00e1mkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Pi\u0165ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Kautzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"2008_CR1","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1093\/eurheartj\/ehx515","volume":"38","author":"K Szummer","year":"2017","unstructured":"Szummer K, Wallentin L, Lindhagen L, Alfredsson J, Erlinge D, Held C et al (2017) Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995\u20132014. Eur Heart J 38:3056\u20133065","journal-title":"Eur Heart J"},{"key":"2008_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1477-7525-1-42","volume":"1","author":"DR Thompson","year":"2003","unstructured":"Thompson DR, Yu C-M (2003) Quality of life in patients with coronary heart disease-I: assessment tools. Health Qual Life Outcomes 1:42","journal-title":"Health Qual Life Outcomes"},{"key":"2008_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/152715440100200312","volume":"2","author":"A Wolfe","year":"2001","unstructured":"Wolfe A (2001) Institute of medicine report: crossing the quality chasm: a new health care system for the 21st century. Policy Polit Nurs Pract 2:233\u2013235","journal-title":"Policy Polit Nurs Pract"},{"key":"2008_CR4","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/CIR.0b013e3182949a2e","volume":"127","author":"JS Rumsfeld","year":"2013","unstructured":"Rumsfeld JS, Alexander KP, Goff DC, Graham MM, Ho PM, Masoudi FA et al (2013) Cardiovascular health: the importance of measuring patient-reported health status. Circulation 127:2233\u20132249","journal-title":"Circulation"},{"key":"2008_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jacc.2005.11.021","volume":"47","author":"PA Heidenreich","year":"2006","unstructured":"Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS et al (2006) Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol 47:752\u2013756","journal-title":"J Am Coll Cardiol"},{"key":"2008_CR6","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jamacardio.2017.3983","volume":"2","author":"Y Pokharel","year":"2017","unstructured":"Pokharel Y, Khariton Y, Tang Y, Nassif ME, Chan PS, Arnold SV et al (2017) Association of serial Kansas City cardiomyopathy questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials. JAMA cardiology 2:1315\u20131321","journal-title":"JAMA cardiology"},{"key":"2008_CR7","first-page":"702","volume":"8","author":"RK Mishra","year":"2015","unstructured":"Mishra RK, Yang W, Roy J, Anderson AH, Bansal N, Chen J et al (2015) Kansas city cardiomyopathy questionnaire score is associated with incident heart failure hospitalization in patients with chronic kidney disease without previously diagnosed heart failure. Circulation 8:702\u2013708","journal-title":"Circulation"},{"key":"2008_CR8","first-page":"2233","volume":"127","author":"JS Rumsfeld","year":"2013","unstructured":"Rumsfeld JS, Alexander KP, Goff DC, Graham MM, Ho PM, Masoudi FA et al (2013) Cardiovascular health: the importance of measuring patient-reported health status. Am Heart Assoc 127:2233\u20132249","journal-title":"Am Heart Assoc"},{"key":"2008_CR9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S et al (2010) The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol 63:1179\u20131194","journal-title":"J Clin Epidemiol"},{"key":"2008_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/nur.4770130405","volume":"13","author":"ME Wewers","year":"1990","unstructured":"Wewers ME, Lowe NK (1990) A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13:227\u2013236","journal-title":"Res Nurs Health"},{"key":"2008_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12955-018-0860-8","volume":"16","author":"M Bahall","year":"2018","unstructured":"Bahall M, Khan K (2018) Quality of life of patients with first-time AMI: a descriptive study. Health Qual Life Outcomes 16:32","journal-title":"Health Qual Life Outcomes"},{"key":"2008_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/archinte.162.5.553","volume":"162","author":"L Pilote","year":"2002","unstructured":"Pilote L, Lauzon C, Huynh T, Dion D, Roux R, Racine N et al (2002) Quality of life after acute myocardial infarction among patients treated at sites with and without on-site availability of angiography. Arch Intern Med 162:553\u2013559","journal-title":"Arch Intern Med"},{"key":"2008_CR13","first-page":"33","volume":"106","author":"T Munyombwe","year":"2020","unstructured":"Munyombwe T, Hall M, Dondo TB, Alabas OA, Gerard O, West RM et al (2020) Quality of life trajectories in survivors of acute myocardial infarction: a national longitudinal study. Heart (Br Cardiac Soc) 106:33\u201339","journal-title":"Heart (Br Cardiac Soc)"},{"key":"2008_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12955-017-0809-3","volume":"15","author":"L Mollon","year":"2017","unstructured":"Mollon L, Bhattacharjee S (2017) Health related quality of life among myocardial infarction survivors in the United States: a propensity score matched analysis. Health Qual Life Outcomes 15:235","journal-title":"Health Qual Life Outcomes"},{"key":"2008_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/medicina46120118","volume":"46","author":"M Stani\u016bt\u0117","year":"2010","unstructured":"Stani\u016bt\u0117 M, Bro\u017eaitien\u0117 J (2010) Changes in health-related quality of life among patients with coronary artery disease: a 2-year follow-up. Medicina (Kaunas) 46:843\u2013850","journal-title":"Medicina (Kaunas)"},{"key":"2008_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002772","volume":"5","author":"MA Navarro","year":"2016","unstructured":"Navarro MA, Gosch KL, Spertus JA, Rumsfeld JS, Ho PM (2016) Chronic kidney disease and health status outcomes following acute myocardial infarction. J Am Heart Assoc 5:e002772","journal-title":"J Am Heart Assoc"},{"key":"2008_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ehf2.13144","volume":"8","author":"D Jen\u010da","year":"2021","unstructured":"Jen\u010da D, Melenovsk\u00fd V, Stehlik J, Stan\u011bk V, Kettner J, Kautzner J et al (2021) Heart failure after myocardial infarction: incidence and predictors. ESC Heart Failure 8:222\u2013237","journal-title":"ESC Heart Failure"},{"key":"2008_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002460","volume":"9","author":"Y Gerber","year":"2016","unstructured":"Gerber Y, Weston SA, Enriquez-Sarano M, Berardi C, Chamberlain AM, Manemann SM et al (2016) Mortality associated with heart failure after myocardial infarction: a contemporary community perspective. Circ Heart Fail 9:e002460","journal-title":"Circ Heart Fail"},{"key":"2008_CR19","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD (2012) Third universal definition of myocardial infarction. Circulation 126:2020\u20132035","journal-title":"Circulation"},{"key":"2008_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jchf.2015.10.015","volume":"4","author":"AA Kelkar","year":"2016","unstructured":"Kelkar AA, Spertus J, Pang P, Pierson RF, Cody RJ, Pina IL et al (2016) Utility of patient-reported outcome instruments in heart failure. JACC Heart Fail 4:165\u2013175","journal-title":"JACC Heart Fail"},{"key":"2008_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10741-013-9394-7","volume":"19","author":"O Garin","year":"2014","unstructured":"Garin O, Herdman M, Vilagut G, Ferrer M, Ribera A, Rajmil L et al (2014) Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures. Heart Fail Rev 19:359\u2013367","journal-title":"Heart Fail Rev"},{"key":"2008_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","volume":"35","author":"CP Green","year":"2000","unstructured":"Green CP, Porter CB, Bresnahan DR, Spertus JA (2000) Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 35:1245\u20131255","journal-title":"J Am Coll Cardiol"},{"key":"2008_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ahj.2004.12.010","volume":"150","author":"J Spertus","year":"2005","unstructured":"Spertus J, Peterson E, Conard MW, Heidenreich PA, Krumholz HM, Jones P et al (2005) Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J 150:707\u2013715","journal-title":"Am Heart J"},{"key":"2008_CR24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/ejhf.1810","volume":"22","author":"J Butler","year":"2020","unstructured":"Butler J, Khan MS, Mori C, Filippatos GS, Ponikowski P, Comin-Colet J et al (2020) Minimal clinically important difference in quality of life scores for patients with heart failure and reduced ejection fraction. Eur J Heart Fail 22:999\u20131005","journal-title":"Eur J Heart Fail"},{"key":"2008_CR25","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa041365","volume":"351","author":"NS Anavekar","year":"2004","unstructured":"Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL et al (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351:1285\u20131295","journal-title":"N Engl J Med"},{"key":"2008_CR26","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/978-0-387-78665-0_111","volume-title":"Handbook of disease burdens and quality of life measures","author":"DR Thomas","year":"2010","unstructured":"Thomas DR (2010) Anemia and quality of life: association with diagnosis and treatment of anemias. In: Preedy VR, Watson RR (eds) Handbook of disease burdens and quality of life measures. Springer, New York, pp 1881\u20131893"},{"key":"2008_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jval.2015.10.010","volume":"19","author":"A Hayes","year":"2016","unstructured":"Hayes A, Arima H, Woodward M, Chalmers J, Poulter N, Hamet P et al (2016) Changes in quality of life associated with complications of diabetes: results from the ADVANCE study. Value in Health 19:36\u201341","journal-title":"Value in Health"},{"key":"2008_CR28","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.2337\/diacare.27.5.1066","volume":"27","author":"RD Goldney","year":"2004","unstructured":"Goldney RD, Phillips PJ, Fisher LJ, Wilson DH (2004) Diabetes, depression, and quality of life. A population study. Diabetes Care 27:1066\u20131070","journal-title":"Diabetes Care"},{"key":"2008_CR29","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1093\/eurheartj\/ehz680","volume":"40","author":"HH van der Wal","year":"2019","unstructured":"van der Wal HH, Grote Beverborg N, Dickstein K, Anker SD, Lang CC, Ng LL et al (2019) Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use. Eur Heart J 40:3616\u20133625","journal-title":"Eur Heart J"},{"key":"2008_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa575","author":"J-P Collet","year":"2020","unstructured":"Collet J-P, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL et al (2020) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa575","journal-title":"Eur Heart J"},{"key":"2008_CR31","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/postgradmedj-2019-137342","volume":"96","author":"J Zhang","year":"2020","unstructured":"Zhang J, Hu S, Jiang Y, Zhou Y (2020) Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: a systematic review and meta-analysis based on 15 randomised controlled trials. Postgrad Med J 96:766\u2013776","journal-title":"Postgrad Med J"},{"key":"2008_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V et al (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020. Eur Heart J 36:657\u2013668","journal-title":"Eur Heart J"},{"key":"2008_CR33","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436\u20132448","journal-title":"N Engl J Med"},{"key":"2008_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/biom8030060","volume":"8","author":"T Zeller","year":"2018","unstructured":"Zeller T, Waldeyer C, Ojeda F, Schnabel RB, Sch\u00e4fer S, Altay A et al (2018) Adverse outcome prediction of iron deficiency in patients with acute coronary syndrome. Biomolecules 8:60","journal-title":"Biomolecules"},{"key":"2008_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/CIRCULATIONAHA.119.044138","volume":"141","author":"MN Kosiborod","year":"2020","unstructured":"Kosiborod MN, Jhund PS, Docherty KF, Diez M, Petrie MC, Verma S et al (2020) Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction. Circulation 141:90\u201399","journal-title":"Circulation"},{"key":"2008_CR36","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383:1413\u20131424","journal-title":"N Engl J Med"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02008-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-022-02008-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02008-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T16:03:57Z","timestamp":1674057837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-022-02008-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2008"],"URL":"https:\/\/doi.org\/10.1007\/s00392-022-02008-z","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"16 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Wohlfahrt has received consulting fees or honoraria from Servier. Dr. Kautzner reports grants and personal fees from Biosense Webster, Biotronik, Boston Scientific, Medtronic, grants and personal fees from Abbott (SJM), personal fees from Merit Medical, Daiichi Sankyo, Boehringer Ingelheim, BMS, Bayer, Merck, MSD, Pfizer, all outside the submitted work. The other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}